By Scott Gottlieb and Mark McClellan (original source Wall Street Journal)
“A new study finds that adding a simple steroid to the treatment of severe Covid-19 cases can significantly reduce deaths. That’s another milestone in the battle against the virus. It shows a path for reducing Covid deaths faster through medical innovation and for keeping the health-care system from being overwhelmed as the epidemic spreads.
The U.S., unlike Europe and Asia, seems to have decided not to crush the virus but try to reduce its spread to a controllable level. The 30,000 cases diagnosed each day probably represent no more than 20% of the total infections. It’s a lot of virus, but mostly manageable, for now. It won’t stay that way.
Death rates are down, partly because older Americans are protecting themselves. More new infections are among younger people less likely to have bad outcomes. But come fall it will be hard to keep infection rates down and isolate older Americans and those with serious health risks. Covid spread will collide with seasonal flu.”
Trump’s critics pine for old-school diplomacy. But Jared Kushner and Steve Witkoff triumphed where Joe Biden’s national security professionals failed. It has been a tough…
No president has ever delivered so much so quickly. But Trump’s biggest challenge lies ahead in Xi Jinping’s China. The U.S. Constitution defines the president…
Since the 1990s, healthcare has been at the heart of America’s political debate and it’s still being contested today. Why is our health system so complicated? And how can we fix it? To help demystify it,…